JULIA HUCKS: Open Payments
NPI 1184123242 · LORIS, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,054 in 49 payments from 18 companies in 2025. Trend: 2023 $732 · 2024 $1,004 · 2025 $1,054
Food & beverage: $1,054
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $308 |
| AstraZeneca Pharmaceuticals LP | 10 | $141 |
| Novo Nordisk Inc | 5 | $121 |
| GlaxoSmithKline, LLC. | 5 | $80 |
| Averitas Pharma Inc. | 2 | $78 |
| Amgen Inc. | 4 | $61 |
| Exact Sciences Corporation | 2 | $31 |
| Ardelyx, Inc. | 2 | $30 |
| ABBVIE INC. | 2 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $28 |
Products named: MOUNJARO, ZEPBOUND, FARXIGA, TRELEGY ELLIPTA, QUTENZA, Ozempic, OTEZLA, Wegovy.
Industry payments across SC — which companies pay providers there.
